BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17100158)

  • 1. Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer.
    Colquhoun AJ; Sundar S; Rajjayabun PH; Griffiths TR; Symonds RP; Mellon JK
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):702-9. PubMed ID: 17100158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
    Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
    Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.
    Moonen L; vd Voet H; de Nijs R; Hart AA; Horenblas S; Bartelink H
    Radiother Oncol; 1998 Nov; 49(2):149-55. PubMed ID: 10052880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia is associated with poor overall survival but not with inferior local control in patients with muscle invasive bladder carcinoma treated by radical external beam radiotherapy. A retrospective study.
    Joynson CP; Sundar S; Symonds P
    Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):728-34. PubMed ID: 17168207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA analysis in predicting survival of irradiated patients with transitional cell carcinoma of bladder.
    Wijkström H; Nilsson B; Tribukait B
    Br J Urol; 1992 Jan; 69(1):49-55. PubMed ID: 1737253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
    Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
    Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
    Sak SC; Harnden P; Johnston CF; Paul AB; Kiltie AE
    Clin Cancer Res; 2005 Sep; 11(17):6205-11. PubMed ID: 16144922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.
    Mameghan H; Fisher R; Mameghan J; Brook S
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):247-54. PubMed ID: 7836076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; von der Maase H
    Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
    Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Cancer; 1994 Nov; 74(10):2819-27. PubMed ID: 7954243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
    Gospodarowicz MK; Hawkins NV; Rawlings GA; Connolly JG; Jewett MA; Thomas GM; Herman JG; Garrett PG; Chua T; Duncan W
    J Urol; 1989 Dec; 142(6):1448-53; discussion 1453-4. PubMed ID: 2585617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
    Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
    Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.
    Matsumoto H; Matsuyama H; Fukunaga K; Yoshihiro S; Wada T; Naito K
    Br J Cancer; 2004 Sep; 91(6):1025-31. PubMed ID: 15292937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study.
    Osen I; Fosså SD; Majak B; Røtterud R; Berner A
    Br J Urol; 1998 Jun; 81(6):862-9. PubMed ID: 9666772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.